Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Clovis Oncology Inc
(NQ:
CLVS
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 20, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Clovis Oncology Inc
< Previous
1
2
3
4
5
6
7
Next >
Analysts Holding As Pfizer Waits On Two Phase 3 Studies
February 24, 2023
Pfizer has two products with great potential, waiting on phase-3 study results. The resulting revenue increase should also improve share value.
Via
MarketBeat
Topics
Bankruptcy
Exposures
Financial
Legal
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 14, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
December 14, 2022
We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about on Wednesday!
Via
InvestorPlace
Why Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarket
December 14, 2022
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 150.9% to $0.6313 in pre-market trading after the company entered into a definitive merger agreement with GRI Bio.
Via
Benzinga
Cancer Focused Clovis Oncology Files For Bankruptcy
December 12, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
December 14, 2022
On Wednesday, 115 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
December 13, 2022
On Tuesday, 49 companies hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 13, 2022
Via
Benzinga
CLVS Stock Alert: What to Know as Clovis Oncology Files for Bankruptcy
December 12, 2022
Clovis Oncology (CLVS) stock is on the move Monday as investors react to the pharmaceutical company filing for bankruptcy protection.
Via
InvestorPlace
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 13, 2022
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Via
Benzinga
Clovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286
December 12, 2022
From
Clovis Oncology, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
December 08, 2022
Via
Benzinga
25 Penny Stocks to Sell Before They Die
December 07, 2022
Wondering which small-cap companies you should offload before 2023? Here are the top picks for penny stocks to sell while you still can.
Via
InvestorPlace
Why Cannabis Stocks TLRY, CGC, SNDL Are Heating Up Today
December 05, 2022
Cannabis stocks are in the news Monday as investors hold out hope for lawmakers to push through new marijuana laws by year's end.
Via
InvestorPlace
Why Is Bed Bath & Beyond (BBBY) Stock Down 75% in 2022?
December 05, 2022
Bed Bath & Beyond (BBBY) stock has had a poor year even as the company's stock gains today on heavy trading and no real news.
Via
InvestorPlace
Why Is Top Ships (TOPS) Stock Down 59% Today?
December 05, 2022
Top Ships (TOPS) stock is falling hard on Monday after the ocean shipping company announced the pricing of a public offering.
Via
InvestorPlace
Dear CLVS Stock Fans, Get Ready for a Bankruptcy Filing
December 05, 2022
Investors in Clovis Oncology (CLVS) stock will want to prepare for a bankruptcy filing following a warning from the pharmaceutical company.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
December 05, 2022
Via
Benzinga
Why Top Ships Shares Are Trading Lower By Over 60%; Here Are 24 Stocks Moving Premarket
December 05, 2022
Gainers Cosmos Holdings Inc. (NASDAQ: COSM) shares rose 18.1% to $0.6316 in pre-market trading after jumping over 34% on Friday. Cosmos Holdings, last month, posted Q3 loss of $0.08 per share.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 05, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
December 05, 2022
The biggest pre-market stock movers for Monday include many Chinese shares that traders will want to keep an eye on today!
Via
InvestorPlace
7 Stocks to Sell Right Now… and 1 to Buy
November 18, 2022
Although red ink can sometimes bring an opportunity for contrarianism, these (except one) market ideas represent stocks to sell.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
November 14, 2022
Gainers
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
November 10, 2022
Upgrades
Via
Benzinga
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
November 15, 2022
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...
Via
Benzinga
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
November 10, 2022
Gainers
Via
Benzinga
Nasdaq Drops 200 Points; Meta Platforms Shares Jump
November 09, 2022
U.S. stocks traded lower toward the end of trading , with the Nasdaq Composite dropping 200 points on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 09, 2022
Gainers
Via
Benzinga
Why Is Clovis Oncology (CLVS) Stock Down 72% Today?
November 09, 2022
Clovis Oncology (CLVS) stock is crashing on Wednesday as investors react to news of the drug company running out of cash!
Via
InvestorPlace
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session
November 09, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.